MedPath
PPB Approval

TAVALISSE TABLETS 100MG

HK-67618

Prescription only Medicines

October 28, 2022

Company Information

Company Details

UNIT 417, 4/F, LIPPO CTR TOWER TWO, NO 89 QUEENSWAY, ADMIRALTY, HONG KONG

Active Ingredients

fostamatinib (as disodium hexahydrate)

Drug Monographs

Fostamatinib

福他替尼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAVALISSE TABLETS 100MG - PPB 批准文号 | MedPath